Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Humanized monoclonal antibody XGFR-4 targets two signaling pathways in cancer

May 6, 2011

Aquaporin-9 expression demonstrated in malignant glioma biopsies

May 5, 2011

Glaucoma candidate ATS-907 shows promising efficacy and safety profile

May 5, 2011

New MAb targeting anti-Muellerian hormone type-2 receptor suppresses ovarian tumors in vivo

May 5, 2011

BiTE antibody MT-112/BAY-2010112 targets prostate cancer

May 5, 2011

SYL-1001 confers analgesia in animal model of ocular pain

May 5, 2011

Hutchison MediPharma presents preclinical data on new small-molecule anticancer agents

May 5, 2011

Methamphetamine-targeted dendribodies show no toxicity in vitro

May 4, 2011

Humanized MAb NEO-201 shows preclinical promise for treatment of solid tumors

May 4, 2011

New frizzled SMO receptor antagonist SEN-450 inhibits tumor growth in vivo

May 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...